{"id":407730,"date":"2025-10-12T00:15:00","date_gmt":"2025-10-11T22:15:00","guid":{"rendered":"https:\/\/medizinonline.com\/nouveaux-horizons-des-inhibiteurs-de-btk-a-la-remyelinisation\/"},"modified":"2025-10-11T23:38:30","modified_gmt":"2025-10-11T21:38:30","slug":"nouveaux-horizons-des-inhibiteurs-de-btk-a-la-remyelinisation","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/nouveaux-horizons-des-inhibiteurs-de-btk-a-la-remyelinisation\/","title":{"rendered":"Nouveaux horizons : des inhibiteurs de BTK \u00e0 la remy\u00e9linisation"},"content":{"rendered":"\n<p><strong>Les formes progressives de la scl\u00e9rose en plaques &#8211; la SEP primaire progressive (PPMS) et la SEP secondaire progressive (SPMS) &#8211; posent des d\u00e9fis particuliers aux neurologues depuis des d\u00e9cennies. Contrairement \u00e0 la SEP r\u00e9currente-r\u00e9mittente (RRMS), pour laquelle le contr\u00f4le de l&#8217;inflammation par des traitements modificateurs de la maladie est devenu la norme clinique, les progr\u00e8s th\u00e9rapeutiques dans le spectre progressif restent fragmentaires. Ces derni\u00e8res ann\u00e9es, cependant, de nouvelles approches ont \u00e9merg\u00e9 : des immunomodulateurs cibl\u00e9s aux inhibiteurs de la tyrosine kinase Bruton, en passant par des strat\u00e9gies de remy\u00e9linisation et des techniques cellulaires et g\u00e9n\u00e9tiques innovantes.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fnouveaux-horizons-des-inhibiteurs-de-btk-a-la-remyelinisation%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Les formes progressives de la scl\u00e9rose en plaques &#8211; la SEP primaire progressive (PPMS) et la SEP secondaire progressive (SPMS) &#8211; posent des d\u00e9fis particuliers aux neurologues depuis des d\u00e9cennies&#8230;.&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fnouveaux-horizons-des-inhibiteurs-de-btk-a-la-remyelinisation%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":407734,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Scl\u00e9rose en plaques progressive  ","footnotes":""},"category":[11527,11531,11417,11383,11549],"tags":[84985,74178,12371,84983,84984],"powerkit_post_featured":[],"class_list":["post-407730","post","type-post","status-publish","format-standard","has-post-thumbnail","category-etudes","category-formation-continue","category-genetique","category-neurologie-fr","category-rx-fr","tag-fenebrutinib-fr","tag-remyelinisation","tag-sclerose-en-plaques","tag-sep-progressive","tag-tolebrutinib-fr","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-08 14:36:38","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":407724,"slug":"nuovi-orizzonti-dagli-inibitori-di-btk-alla-rimielinizzazione","post_title":"Nuovi orizzonti: dagli inibitori di BTK alla rimielinizzazione","href":"https:\/\/medizinonline.com\/it\/nuovi-orizzonti-dagli-inibitori-di-btk-alla-rimielinizzazione\/"},"pt_PT":{"locale":"pt_PT","id":407744,"slug":"novos-horizontes-dos-inibidores-da-btk-a-remielinizacao","post_title":"Novos horizontes: dos inibidores da BTK \u00e0 remieliniza\u00e7\u00e3o","href":"https:\/\/medizinonline.com\/pt-pt\/novos-horizontes-dos-inibidores-da-btk-a-remielinizacao\/"},"es_ES":{"locale":"es_ES","id":407739,"slug":"nuevos-horizontes-de-los-inhibidores-de-btk-a-la-remielinizacion","post_title":"Nuevos horizontes: de los inhibidores de BTK a la remielinizaci\u00f3n","href":"https:\/\/medizinonline.com\/es\/nuevos-horizontes-de-los-inhibidores-de-btk-a-la-remielinizacion\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/407730","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=407730"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/407730\/revisions"}],"predecessor-version":[{"id":407735,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/407730\/revisions\/407735"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/407734"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=407730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=407730"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=407730"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=407730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}